カテゴリー： LP Information, 世界, 部品/材料

世界のルベサルタン市場予測 2023年-2029年

◆英語タイトル：Global lrbesartan Market Growth 2023-2029
	◆商品コード：LP23JU2258 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：121 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のルベサルタン市場」は、過去の販売実績から2022年の世界のルベサルタンの総販売量を検討し、2023年から2029年の予測されるルベサルタンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のルベサルタンの市場規模を掲載し、XXX百万米ドル規模の世界のルベサルタン市場の詳細な分析を提供します。本インサイトレポートは、世界のルベサルタン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のルベサルタン市場における各社の独自のポジションをより深く理解するために、ルベサルタン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のルベサルタン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ルベサルタンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ルベサルタンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ルベサルタンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ルベサルタンの世界主要メーカーとしては、Euroapi、 Tenatra Chemie、 Jai Radhe Sales、 Dr. Reddy's Laboratories、 Sanofi、 Octavius Pharma、 Teva、 Piramal Group、 Zydus Lifesciences、 Macleods Pharmaceuticals、 Cipla、 Siegfried AG、 Aurobindo、 Alembic Pharmaceuticals、 MSN Laboratories、 Calyx Chemicals and Pharmaceuticals、 Divis Laboratories、 Mylan、 Hetero Drugs、 Apeloa Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のルベサルタン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではルベサルタン市場をセグメンテーションし、種類別 (純度98%以上、純度99%以上)、用途別 (研究機関、製薬企業、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度98%以上、純度99%以上

・用途別区分：研究機関、製薬企業、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のルベサルタン市場の10年間の市場状況・展望は？
・世界および地域別に見たルベサルタン市場成長の要因は何か？
・ルベサルタンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・ルベサルタンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ルベサルタンの年間販売量2018-2029、地域別現状・将来分析
・ルベサルタンの種類別セグメント：純度98%以上、純度99%以上
・ルベサルタンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ルベサルタンの用途別セグメント：研究機関、製薬企業、その他
・ルベサルタンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のルベサルタン市場
・企業別のグローバルルベサルタン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のルベサルタンの年間売上：2018-2023年の売上、市場シェア
・企業別のルベサルタン販売価格
・主要企業のルベサルタン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ルベサルタンの地域別レビュー
・地域別のルベサルタン市場規模2018-2023：年間販売量、売上
・主要国別のルベサルタン市場規模2018-2023：年間販売量、売上
・南北アメリカのルベサルタン販売の成長
・アジア太平洋のルベサルタン販売の成長
・ヨーロッパのルベサルタン販売の成長
・中東・アフリカのルベサルタン販売の成長

南北アメリカ市場
・南北アメリカの国別のルベサルタン販売量、売上（2018-2023）
・南北アメリカのルベサルタンの種類別販売量
・南北アメリカのルベサルタンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のルベサルタン販売量、売上（2018-2023）
・アジア太平洋のルベサルタンの種類別販売量
・アジア太平洋のルベサルタンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のルベサルタン販売量、売上（2018-2023）
・ヨーロッパのルベサルタンの種類別販売量
・ヨーロッパのルベサルタンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のルベサルタン販売量、売上（2018-2023）
・中東・アフリカのルベサルタンの種類別販売量
・中東・アフリカのルベサルタンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ルベサルタンの製造コスト構造分析
・ルベサルタンの製造プロセス分析
・ルベサルタンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ルベサルタンの主要なグローバル販売業者
・ルベサルタンの主要なグローバル顧客

地域別のルベサルタン市場予測レビュー
・地域別のルベサルタン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ルベサルタンの種類別市場規模予測
・ルベサルタンの用途別市場規模予測

主要企業分析
Euroapi、 Tenatra Chemie、 Jai Radhe Sales、 Dr. Reddy's Laboratories、 Sanofi、 Octavius Pharma、 Teva、 Piramal Group、 Zydus Lifesciences、 Macleods Pharmaceuticals、 Cipla、 Siegfried AG、 Aurobindo、 Alembic Pharmaceuticals、 MSN Laboratories、 Calyx Chemicals and Pharmaceuticals、 Divis Laboratories、 Mylan、 Hetero Drugs、 Apeloa Pharmaceutical
・企業情報
・ルベサルタン製品
・ルベサルタン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Irbesartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Irbesartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.
LPI (LP Information)’ newest research report, the “lrbesartan Industry Forecast” looks at past sales and reviews total world lrbesartan sales in 2022, providing a comprehensive analysis by region and market sector of projected lrbesartan sales for 2023 through 2029. With lrbesartan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world lrbesartan industry.
This Insight Report provides a comprehensive analysis of the global lrbesartan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on lrbesartan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global lrbesartan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for lrbesartan and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global lrbesartan.
The global lrbesartan market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for lrbesartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for lrbesartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for lrbesartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key lrbesartan players cover Euroapi, Tenatra Chemie, Jai Radhe Sales, Dr. Reddy’s Laboratories, Sanofi, Octavius Pharma, Teva, Piramal Group and Zydus Lifesciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of lrbesartan market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity ≥ 98 %
Purity ≥ 99 %
Segmentation by application
Research Institute
Pharmaceutical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Euroapi
Tenatra Chemie
Jai Radhe Sales
Dr. Reddy’s Laboratories
Sanofi
Octavius Pharma
Teva
Piramal Group
Zydus Lifesciences
Macleods Pharmaceuticals
Cipla
Siegfried AG
Aurobindo
Alembic Pharmaceuticals
MSN Laboratories
Calyx Chemicals and Pharmaceuticals
Divis Laboratories
Mylan
Hetero Drugs
Apeloa Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global lrbesartan market?
What factors are driving lrbesartan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do lrbesartan market opportunities vary by end market size?
How does lrbesartan break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global lrbesartan Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for lrbesartan by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for lrbesartan by Country/Region, 2018, 2022 & 2029
2.2 lrbesartan Segment by Type
2.2.1 Purity ≥ 98 %
2.2.2 Purity ≥ 99 %
2.3 lrbesartan Sales by Type
2.3.1 Global lrbesartan Sales Market Share by Type (2018-2023)
2.3.2 Global lrbesartan Revenue and Market Share by Type (2018-2023)
2.3.3 Global lrbesartan Sale Price by Type (2018-2023)
2.4 lrbesartan Segment by Application
2.4.1 Research Institute
2.4.2 Pharmaceutical
2.4.3 Others
2.5 lrbesartan Sales by Application
2.5.1 Global lrbesartan Sale Market Share by Application (2018-2023)
2.5.2 Global lrbesartan Revenue and Market Share by Application (2018-2023)
2.5.3 Global lrbesartan Sale Price by Application (2018-2023)
3 Global lrbesartan by Company
3.1 Global lrbesartan Breakdown Data by Company
3.1.1 Global lrbesartan Annual Sales by Company (2018-2023)
3.1.2 Global lrbesartan Sales Market Share by Company (2018-2023)
3.2 Global lrbesartan Annual Revenue by Company (2018-2023)
3.2.1 Global lrbesartan Revenue by Company (2018-2023)
3.2.2 Global lrbesartan Revenue Market Share by Company (2018-2023)
3.3 Global lrbesartan Sale Price by Company
3.4 Key Manufacturers lrbesartan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers lrbesartan Product Location Distribution
3.4.2 Players lrbesartan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for lrbesartan by Geographic Region
4.1 World Historic lrbesartan Market Size by Geographic Region (2018-2023)
4.1.1 Global lrbesartan Annual Sales by Geographic Region (2018-2023)
4.1.2 Global lrbesartan Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic lrbesartan Market Size by Country/Region (2018-2023)
4.2.1 Global lrbesartan Annual Sales by Country/Region (2018-2023)
4.2.2 Global lrbesartan Annual Revenue by Country/Region (2018-2023)
4.3 Americas lrbesartan Sales Growth
4.4 APAC lrbesartan Sales Growth
4.5 Europe lrbesartan Sales Growth
4.6 Middle East & Africa lrbesartan Sales Growth
5 Americas
5.1 Americas lrbesartan Sales by Country
5.1.1 Americas lrbesartan Sales by Country (2018-2023)
5.1.2 Americas lrbesartan Revenue by Country (2018-2023)
5.2 Americas lrbesartan Sales by Type
5.3 Americas lrbesartan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC lrbesartan Sales by Region
6.1.1 APAC lrbesartan Sales by Region (2018-2023)
6.1.2 APAC lrbesartan Revenue by Region (2018-2023)
6.2 APAC lrbesartan Sales by Type
6.3 APAC lrbesartan Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe lrbesartan by Country
7.1.1 Europe lrbesartan Sales by Country (2018-2023)
7.1.2 Europe lrbesartan Revenue by Country (2018-2023)
7.2 Europe lrbesartan Sales by Type
7.3 Europe lrbesartan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa lrbesartan by Country
8.1.1 Middle East & Africa lrbesartan Sales by Country (2018-2023)
8.1.2 Middle East & Africa lrbesartan Revenue by Country (2018-2023)
8.2 Middle East & Africa lrbesartan Sales by Type
8.3 Middle East & Africa lrbesartan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of lrbesartan
10.3 Manufacturing Process Analysis of lrbesartan
10.4 Industry Chain Structure of lrbesartan
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 lrbesartan Distributors
11.3 lrbesartan Customer
12 World Forecast Review for lrbesartan by Geographic Region
12.1 Global lrbesartan Market Size Forecast by Region
12.1.1 Global lrbesartan Forecast by Region (2024-2029)
12.1.2 Global lrbesartan Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global lrbesartan Forecast by Type
12.7 Global lrbesartan Forecast by Application
13 Key Players Analysis
13.1 Euroapi
13.1.1 Euroapi Company Information
13.1.2 Euroapi lrbesartan Product Portfolios and Specifications
13.1.3 Euroapi lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Euroapi Main Business Overview
13.1.5 Euroapi Latest Developments
13.2 Tenatra Chemie
13.2.1 Tenatra Chemie Company Information
13.2.2 Tenatra Chemie lrbesartan Product Portfolios and Specifications
13.2.3 Tenatra Chemie lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Tenatra Chemie Main Business Overview
13.2.5 Tenatra Chemie Latest Developments
13.3 Jai Radhe Sales
13.3.1 Jai Radhe Sales Company Information
13.3.2 Jai Radhe Sales lrbesartan Product Portfolios and Specifications
13.3.3 Jai Radhe Sales lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Jai Radhe Sales Main Business Overview
13.3.5 Jai Radhe Sales Latest Developments
13.4 Dr. Reddy’s Laboratories
13.4.1 Dr. Reddy’s Laboratories Company Information
13.4.2 Dr. Reddy’s Laboratories lrbesartan Product Portfolios and Specifications
13.4.3 Dr. Reddy’s Laboratories lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dr. Reddy’s Laboratories Main Business Overview
13.4.5 Dr. Reddy’s Laboratories Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi lrbesartan Product Portfolios and Specifications
13.5.3 Sanofi lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Octavius Pharma
13.6.1 Octavius Pharma Company Information
13.6.2 Octavius Pharma lrbesartan Product Portfolios and Specifications
13.6.3 Octavius Pharma lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Octavius Pharma Main Business Overview
13.6.5 Octavius Pharma Latest Developments
13.7 Teva
13.7.1 Teva Company Information
13.7.2 Teva lrbesartan Product Portfolios and Specifications
13.7.3 Teva lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Teva Main Business Overview
13.7.5 Teva Latest Developments
13.8 Piramal Group
13.8.1 Piramal Group Company Information
13.8.2 Piramal Group lrbesartan Product Portfolios and Specifications
13.8.3 Piramal Group lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Piramal Group Main Business Overview
13.8.5 Piramal Group Latest Developments
13.9 Zydus Lifesciences
13.9.1 Zydus Lifesciences Company Information
13.9.2 Zydus Lifesciences lrbesartan Product Portfolios and Specifications
13.9.3 Zydus Lifesciences lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Zydus Lifesciences Main Business Overview
13.9.5 Zydus Lifesciences Latest Developments
13.10 Macleods Pharmaceuticals
13.10.1 Macleods Pharmaceuticals Company Information
13.10.2 Macleods Pharmaceuticals lrbesartan Product Portfolios and Specifications
13.10.3 Macleods Pharmaceuticals lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Macleods Pharmaceuticals Main Business Overview
13.10.5 Macleods Pharmaceuticals Latest Developments
13.11 Cipla
13.11.1 Cipla Company Information
13.11.2 Cipla lrbesartan Product Portfolios and Specifications
13.11.3 Cipla lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Cipla Main Business Overview
13.11.5 Cipla Latest Developments
13.12 Siegfried AG
13.12.1 Siegfried AG Company Information
13.12.2 Siegfried AG lrbesartan Product Portfolios and Specifications
13.12.3 Siegfried AG lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Siegfried AG Main Business Overview
13.12.5 Siegfried AG Latest Developments
13.13 Aurobindo
13.13.1 Aurobindo Company Information
13.13.2 Aurobindo lrbesartan Product Portfolios and Specifications
13.13.3 Aurobindo lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Aurobindo Main Business Overview
13.13.5 Aurobindo Latest Developments
13.14 Alembic Pharmaceuticals
13.14.1 Alembic Pharmaceuticals Company Information
13.14.2 Alembic Pharmaceuticals lrbesartan Product Portfolios and Specifications
13.14.3 Alembic Pharmaceuticals lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Alembic Pharmaceuticals Main Business Overview
13.14.5 Alembic Pharmaceuticals Latest Developments
13.15 MSN Laboratories
13.15.1 MSN Laboratories Company Information
13.15.2 MSN Laboratories lrbesartan Product Portfolios and Specifications
13.15.3 MSN Laboratories lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 MSN Laboratories Main Business Overview
13.15.5 MSN Laboratories Latest Developments
13.16 Calyx Chemicals and Pharmaceuticals
13.16.1 Calyx Chemicals and Pharmaceuticals Company Information
13.16.2 Calyx Chemicals and Pharmaceuticals lrbesartan Product Portfolios and Specifications
13.16.3 Calyx Chemicals and Pharmaceuticals lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Calyx Chemicals and Pharmaceuticals Main Business Overview
13.16.5 Calyx Chemicals and Pharmaceuticals Latest Developments
13.17 Divis Laboratories
13.17.1 Divis Laboratories Company Information
13.17.2 Divis Laboratories lrbesartan Product Portfolios and Specifications
13.17.3 Divis Laboratories lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Divis Laboratories Main Business Overview
13.17.5 Divis Laboratories Latest Developments
13.18 Mylan
13.18.1 Mylan Company Information
13.18.2 Mylan lrbesartan Product Portfolios and Specifications
13.18.3 Mylan lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Mylan Main Business Overview
13.18.5 Mylan Latest Developments
13.19 Hetero Drugs
13.19.1 Hetero Drugs Company Information
13.19.2 Hetero Drugs lrbesartan Product Portfolios and Specifications
13.19.3 Hetero Drugs lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Hetero Drugs Main Business Overview
13.19.5 Hetero Drugs Latest Developments
13.20 Apeloa Pharmaceutical
13.20.1 Apeloa Pharmaceutical Company Information
13.20.2 Apeloa Pharmaceutical lrbesartan Product Portfolios and Specifications
13.20.3 Apeloa Pharmaceutical lrbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Apeloa Pharmaceutical Main Business Overview
13.20.5 Apeloa Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. lrbesartan Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. lrbesartan Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity ≥ 98 %
Table 4. Major Players of Purity ≥ 99 %
Table 5. Global lrbesartan Sales by Type (2018-2023) & (Tons)
Table 6. Global lrbesartan Sales Market Share by Type (2018-2023)
Table 7. Global lrbesartan Revenue by Type (2018-2023) & ($ million)
Table 8. Global lrbesartan Revenue Market Share by Type (2018-2023)
Table 9. Global lrbesartan Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global lrbesartan Sales by Application (2018-2023) & (Tons)
Table 11. Global lrbesartan Sales Market Share by Application (2018-2023)
Table 12. Global lrbesartan Revenue by Application (2018-2023)
Table 13. Global lrbesartan Revenue Market Share by Application (2018-2023)
Table 14. Global lrbesartan Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global lrbesartan Sales by Company (2018-2023) & (Tons)
Table 16. Global lrbesartan Sales Market Share by Company (2018-2023)
Table 17. Global lrbesartan Revenue by Company (2018-2023) ($ Millions)
Table 18. Global lrbesartan Revenue Market Share by Company (2018-2023)
Table 19. Global lrbesartan Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers lrbesartan Producing Area Distribution and Sales Area
Table 21. Players lrbesartan Products Offered
Table 22. lrbesartan Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global lrbesartan Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global lrbesartan Sales Market Share Geographic Region (2018-2023)
Table 27. Global lrbesartan Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global lrbesartan Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global lrbesartan Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global lrbesartan Sales Market Share by Country/Region (2018-2023)
Table 31. Global lrbesartan Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global lrbesartan Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas lrbesartan Sales by Country (2018-2023) & (Tons)
Table 34. Americas lrbesartan Sales Market Share by Country (2018-2023)
Table 35. Americas lrbesartan Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas lrbesartan Revenue Market Share by Country (2018-2023)
Table 37. Americas lrbesartan Sales by Type (2018-2023) & (Tons)
Table 38. Americas lrbesartan Sales by Application (2018-2023) & (Tons)
Table 39. APAC lrbesartan Sales by Region (2018-2023) & (Tons)
Table 40. APAC lrbesartan Sales Market Share by Region (2018-2023)
Table 41. APAC lrbesartan Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC lrbesartan Revenue Market Share by Region (2018-2023)
Table 43. APAC lrbesartan Sales by Type (2018-2023) & (Tons)
Table 44. APAC lrbesartan Sales by Application (2018-2023) & (Tons)
Table 45. Europe lrbesartan Sales by Country (2018-2023) & (Tons)
Table 46. Europe lrbesartan Sales Market Share by Country (2018-2023)
Table 47. Europe lrbesartan Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe lrbesartan Revenue Market Share by Country (2018-2023)
Table 49. Europe lrbesartan Sales by Type (2018-2023) & (Tons)
Table 50. Europe lrbesartan Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa lrbesartan Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa lrbesartan Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa lrbesartan Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa lrbesartan Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa lrbesartan Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa lrbesartan Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of lrbesartan
Table 58. Key Market Challenges & Risks of lrbesartan
Table 59. Key Industry Trends of lrbesartan
Table 60. lrbesartan Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. lrbesartan Distributors List
Table 63. lrbesartan Customer List
Table 64. Global lrbesartan Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global lrbesartan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas lrbesartan Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas lrbesartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC lrbesartan Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC lrbesartan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe lrbesartan Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe lrbesartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa lrbesartan Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa lrbesartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global lrbesartan Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global lrbesartan Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global lrbesartan Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global lrbesartan Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Euroapi Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 79. Euroapi lrbesartan Product Portfolios and Specifications
Table 80. Euroapi lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Euroapi Main Business
Table 82. Euroapi Latest Developments
Table 83. Tenatra Chemie Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 84. Tenatra Chemie lrbesartan Product Portfolios and Specifications
Table 85. Tenatra Chemie lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Tenatra Chemie Main Business
Table 87. Tenatra Chemie Latest Developments
Table 88. Jai Radhe Sales Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 89. Jai Radhe Sales lrbesartan Product Portfolios and Specifications
Table 90. Jai Radhe Sales lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Jai Radhe Sales Main Business
Table 92. Jai Radhe Sales Latest Developments
Table 93. Dr. Reddy's Laboratories Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 94. Dr. Reddy's Laboratories lrbesartan Product Portfolios and Specifications
Table 95. Dr. Reddy's Laboratories lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Dr. Reddy's Laboratories Main Business
Table 97. Dr. Reddy's Laboratories Latest Developments
Table 98. Sanofi Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi lrbesartan Product Portfolios and Specifications
Table 100. Sanofi lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Octavius Pharma Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 104. Octavius Pharma lrbesartan Product Portfolios and Specifications
Table 105. Octavius Pharma lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Octavius Pharma Main Business
Table 107. Octavius Pharma Latest Developments
Table 108. Teva Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 109. Teva lrbesartan Product Portfolios and Specifications
Table 110. Teva lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Teva Main Business
Table 112. Teva Latest Developments
Table 113. Piramal Group Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 114. Piramal Group lrbesartan Product Portfolios and Specifications
Table 115. Piramal Group lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Piramal Group Main Business
Table 117. Piramal Group Latest Developments
Table 118. Zydus Lifesciences Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 119. Zydus Lifesciences lrbesartan Product Portfolios and Specifications
Table 120. Zydus Lifesciences lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Zydus Lifesciences Main Business
Table 122. Zydus Lifesciences Latest Developments
Table 123. Macleods Pharmaceuticals Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 124. Macleods Pharmaceuticals lrbesartan Product Portfolios and Specifications
Table 125. Macleods Pharmaceuticals lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Macleods Pharmaceuticals Main Business
Table 127. Macleods Pharmaceuticals Latest Developments
Table 128. Cipla Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 129. Cipla lrbesartan Product Portfolios and Specifications
Table 130. Cipla lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Cipla Main Business
Table 132. Cipla Latest Developments
Table 133. Siegfried AG Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 134. Siegfried AG lrbesartan Product Portfolios and Specifications
Table 135. Siegfried AG lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Siegfried AG Main Business
Table 137. Siegfried AG Latest Developments
Table 138. Aurobindo Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 139. Aurobindo lrbesartan Product Portfolios and Specifications
Table 140. Aurobindo lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. Aurobindo Main Business
Table 142. Aurobindo Latest Developments
Table 143. Alembic Pharmaceuticals Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 144. Alembic Pharmaceuticals lrbesartan Product Portfolios and Specifications
Table 145. Alembic Pharmaceuticals lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. Alembic Pharmaceuticals Main Business
Table 147. Alembic Pharmaceuticals Latest Developments
Table 148. MSN Laboratories Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 149. MSN Laboratories lrbesartan Product Portfolios and Specifications
Table 150. MSN Laboratories lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 151. MSN Laboratories Main Business
Table 152. MSN Laboratories Latest Developments
Table 153. Calyx Chemicals and Pharmaceuticals Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 154. Calyx Chemicals and Pharmaceuticals lrbesartan Product Portfolios and Specifications
Table 155. Calyx Chemicals and Pharmaceuticals lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 156. Calyx Chemicals and Pharmaceuticals Main Business
Table 157. Calyx Chemicals and Pharmaceuticals Latest Developments
Table 158. Divis Laboratories Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 159. Divis Laboratories lrbesartan Product Portfolios and Specifications
Table 160. Divis Laboratories lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 161. Divis Laboratories Main Business
Table 162. Divis Laboratories Latest Developments
Table 163. Mylan Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 164. Mylan lrbesartan Product Portfolios and Specifications
Table 165. Mylan lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 166. Mylan Main Business
Table 167. Mylan Latest Developments
Table 168. Hetero Drugs Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 169. Hetero Drugs lrbesartan Product Portfolios and Specifications
Table 170. Hetero Drugs lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 171. Hetero Drugs Main Business
Table 172. Hetero Drugs Latest Developments
Table 173. Apeloa Pharmaceutical Basic Information, lrbesartan Manufacturing Base, Sales Area and Its Competitors
Table 174. Apeloa Pharmaceutical lrbesartan Product Portfolios and Specifications
Table 175. Apeloa Pharmaceutical lrbesartan Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 176. Apeloa Pharmaceutical Main Business
Table 177. Apeloa Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of lrbesartan
Figure 2. lrbesartan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global lrbesartan Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global lrbesartan Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. lrbesartan Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity ≥ 98 %
Figure 10. Product Picture of Purity ≥ 99 %
Figure 11. Global lrbesartan Sales Market Share by Type in 2022
Figure 12. Global lrbesartan Revenue Market Share by Type (2018-2023)
Figure 13. lrbesartan Consumed in Research Institute
Figure 14. Global lrbesartan Market: Research Institute (2018-2023) & (Tons)
Figure 15. lrbesartan Consumed in Pharmaceutical
Figure 16. Global lrbesartan Market: Pharmaceutical (2018-2023) & (Tons)
Figure 17. lrbesartan Consumed in Others
Figure 18. Global lrbesartan Market: Others (2018-2023) & (Tons)
Figure 19. Global lrbesartan Sales Market Share by Application (2022)
Figure 20. Global lrbesartan Revenue Market Share by Application in 2022
Figure 21. lrbesartan Sales Market by Company in 2022 (Tons)
Figure 22. Global lrbesartan Sales Market Share by Company in 2022
Figure 23. lrbesartan Revenue Market by Company in 2022 ($ Million)
Figure 24. Global lrbesartan Revenue Market Share by Company in 2022
Figure 25. Global lrbesartan Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global lrbesartan Revenue Market Share by Geographic Region in 2022
Figure 27. Americas lrbesartan Sales 2018-2023 (Tons)
Figure 28. Americas lrbesartan Revenue 2018-2023 ($ Millions)
Figure 29. APAC lrbesartan Sales 2018-2023 (Tons)
Figure 30. APAC lrbesartan Revenue 2018-2023 ($ Millions)
Figure 31. Europe lrbesartan Sales 2018-2023 (Tons)
Figure 32. Europe lrbesartan Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa lrbesartan Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa lrbesartan Revenue 2018-2023 ($ Millions)
Figure 35. Americas lrbesartan Sales Market Share by Country in 2022
Figure 36. Americas lrbesartan Revenue Market Share by Country in 2022
Figure 37. Americas lrbesartan Sales Market Share by Type (2018-2023)
Figure 38. Americas lrbesartan Sales Market Share by Application (2018-2023)
Figure 39. United States lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC lrbesartan Sales Market Share by Region in 2022
Figure 44. APAC lrbesartan Revenue Market Share by Regions in 2022
Figure 45. APAC lrbesartan Sales Market Share by Type (2018-2023)
Figure 46. APAC lrbesartan Sales Market Share by Application (2018-2023)
Figure 47. China lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 51. India lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe lrbesartan Sales Market Share by Country in 2022
Figure 55. Europe lrbesartan Revenue Market Share by Country in 2022
Figure 56. Europe lrbesartan Sales Market Share by Type (2018-2023)
Figure 57. Europe lrbesartan Sales Market Share by Application (2018-2023)
Figure 58. Germany lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 59. France lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa lrbesartan Sales Market Share by Country in 2022
Figure 64. Middle East & Africa lrbesartan Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa lrbesartan Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa lrbesartan Sales Market Share by Application (2018-2023)
Figure 67. Egypt lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country lrbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of lrbesartan in 2022
Figure 73. Manufacturing Process Analysis of lrbesartan
Figure 74. Industry Chain Structure of lrbesartan
Figure 75. Channels of Distribution
Figure 76. Global lrbesartan Sales Market Forecast by Region (2024-2029)
Figure 77. Global lrbesartan Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global lrbesartan Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global lrbesartan Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global lrbesartan Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global lrbesartan Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のルベサルタン市場予測 2023年-2029年(Global lrbesartan Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のルベサルタン市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp